These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 38791209)

  • 1. Revolution in Cancer Treatment: How Are Intelligently Designed Nanostructures Changing the Game?
    Gül D; Önal Acet B; Lu Q; Stauber RH; Odabaşı M; Acet Ö
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinspired approaches for cancer nanotheranostics.
    Evangelopoulos M; Tasciotti E
    Nanomedicine (Lond); 2017 Jan; 12(1):5-7. PubMed ID: 27876435
    [No Abstract]   [Full Text] [Related]  

  • 3. Nano revolution of DNA nanostructures redefining cancer therapeutics-A comprehensive review.
    Yadav K; Gnanakani SPE; Sahu KK; Veni Chikkula CK; Vaddi PS; Srilakshmi S; Yadav R; Sucheta ; Dubey A; Minz S; Pradhan M
    Int J Biol Macromol; 2024 Aug; 274(Pt 1):133244. PubMed ID: 38901506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures.
    Chen Y; Chen H; Shi J
    Expert Opin Drug Deliv; 2014 Jun; 11(6):917-30. PubMed ID: 24746014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering DNA scaffolds for delivery of anticancer therapeutics.
    Sun W; Gu Z
    Biomater Sci; 2015 Jul; 3(7):1018-24. PubMed ID: 26221936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery.
    Sharma AK; Gothwal A; Kesharwani P; Alsaab H; Iyer AK; Gupta U
    Drug Discov Today; 2017 Feb; 22(2):314-326. PubMed ID: 27671487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
    Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
    J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomaterials multifunctional behavior for enlightened cancer therapeutics.
    Raju GSR; Dariya B; Mungamuri SK; Chalikonda G; Kang SM; Khan IN; Sushma PS; Nagaraju GP; Pavitra E; Han YK
    Semin Cancer Biol; 2021 Feb; 69():178-189. PubMed ID: 31419527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional Nanoparticles in Precise Cancer Treatment: Considerations in Design and Functionalization of Nanocarriers.
    Lu L; Kang S; Sun C; Sun C; Guo Z; Li J; Zhang T; Luo X; Liu B
    Curr Top Med Chem; 2020; 20(27):2427-2441. PubMed ID: 32842941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
    Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
    Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicines Targeting the Tumor Microenvironment.
    Tong R; Langer R
    Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision Cancer Nanotherapy: Evolving Role of Multifunctional Nanoparticles for Cancer Active Targeting.
    Ahmad A; Khan F; Mishra RK; Khan R
    J Med Chem; 2019 Dec; 62(23):10475-10496. PubMed ID: 31339714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
    Du JZ; Li HJ; Wang J
    Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimuli-responsive drug delivery systems for head and neck cancer therapy.
    Liang J; Yang B; Zhou X; Han Q; Zou J; Cheng L
    Drug Deliv; 2021 Dec; 28(1):272-284. PubMed ID: 33501883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles for Cancer Targeting: Current and Future Directions.
    Swain S; Sahu PK; Beg S; Babu SM
    Curr Drug Deliv; 2016; 13(8):1290-1302. PubMed ID: 27411485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicines for developing cancer nanotherapeutics: from benchtop to bedside and beyond.
    Iqbal J; Abbasi BA; Ahmad R; Mahmood T; Ali B; Khalil AT; Kanwal S; Shah SA; Alam MM; Badshah H; Munir A
    Appl Microbiol Biotechnol; 2018 Nov; 102(22):9449-9470. PubMed ID: 30219952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of transferrin receptors in oncology: the development of functional nano-based drug delivery systems.
    Tortorella S; Karagiannis TC
    Curr Drug Deliv; 2014; 11(4):427-43. PubMed ID: 24387131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Nanotechnology: Recent Trends and Developments in Strategies for Targeting Cancer Cells to Improve Cancer Imaging and Treatment.
    Xu J; Zhou X; Li Y; Tian Y
    Curr Drug Metab; 2017; 18(4):266-279. PubMed ID: 28093991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimuli-responsive polymeric micelles for drug delivery and cancer therapy.
    Zhou Q; Zhang L; Yang T; Wu H
    Int J Nanomedicine; 2018; 13():2921-2942. PubMed ID: 29849457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graphene-based nanomaterials and their potentials in advanced drug delivery and cancer therapy.
    Liu J; Dong J; Zhang T; Peng Q
    J Control Release; 2018 Sep; 286():64-73. PubMed ID: 30031155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.